Marina C. Garassino, MD, on COVID-19 and Thoracic Malignancies: TERAVOLT Registry

August 28, 2020 By The ASCO Post Staff

Marina C. Garassino, MD, of the Istituto Nazionale dei Tumori di Milano, discusses the global registry she and her colleagues created to track and address the 35% higher mortality risk from COVID-19 among patients with lung cancer who are treated with chemotherapy.

Related Content